Endocrine Therapy for Advanced Breast Cancer: Beyond Tamoxifen and Aromatase Inhibitors

E-ISSN： 1875-6301|6|1|51-61

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.6, Iss.1, 2010-02, pp. : 51-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of Aromatase Inhibitors in Endocrine Responsive Breast Cancer: Lessons Learnt from Tamoxifen and CYP2D6 Genotyping

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 13, 2018-01 ,pp. : 1805-1813

Bentham Science Publishers

Access to resources Recommend Favorite

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients

By Eggemann Holm

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 465-470

Springer Publishing Company

Access to resources Recommend Favorite

Aromatase inhibitors in the treatment of early and advanced breast cancer

By Joensuu Heikki Ejlertsen Bent Lønning Per Rutqvist Lars-Erik

Acta Oncologica, Vol. 44, Iss. 1, 2005-02 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

Aromatase Inhibitors: Indications for Breast Cancer Therapy

By Assikis V.J.

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 93-100

Adis International

Access to resources Recommend Favorite

Application status of tamoxifen in endocrine therapy for early breast cancer

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2207-2212

Spandidos Publications

Access to resources Recommend Favorite